1. Home
  2. VLN vs NBTX Comparison

VLN vs NBTX Comparison

Compare VLN & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLN
  • NBTX
  • Stock Information
  • Founded
  • VLN 2006
  • NBTX 2003
  • Country
  • VLN Israel
  • NBTX France
  • Employees
  • VLN N/A
  • NBTX N/A
  • Industry
  • VLN Semiconductors
  • NBTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLN Technology
  • NBTX Health Care
  • Exchange
  • VLN Nasdaq
  • NBTX Nasdaq
  • Market Cap
  • VLN 224.2M
  • NBTX 211.9M
  • IPO Year
  • VLN N/A
  • NBTX 2020
  • Fundamental
  • Price
  • VLN $1.86
  • NBTX $9.70
  • Analyst Decision
  • VLN Strong Buy
  • NBTX Strong Buy
  • Analyst Count
  • VLN 1
  • NBTX 1
  • Target Price
  • VLN $4.00
  • NBTX $8.00
  • AVG Volume (30 Days)
  • VLN 553.5K
  • NBTX 15.1K
  • Earning Date
  • VLN 11-05-2025
  • NBTX 09-18-2025
  • Dividend Yield
  • VLN N/A
  • NBTX N/A
  • EPS Growth
  • VLN N/A
  • NBTX N/A
  • EPS
  • VLN N/A
  • NBTX N/A
  • Revenue
  • VLN $66,590,000.00
  • NBTX N/A
  • Revenue This Year
  • VLN $18.22
  • NBTX N/A
  • Revenue Next Year
  • VLN $17.94
  • NBTX $74.67
  • P/E Ratio
  • VLN N/A
  • NBTX N/A
  • Revenue Growth
  • VLN 8.70
  • NBTX N/A
  • 52 Week Low
  • VLN $1.67
  • NBTX $2.76
  • 52 Week High
  • VLN $3.50
  • NBTX $10.59
  • Technical
  • Relative Strength Index (RSI)
  • VLN 33.27
  • NBTX 62.98
  • Support Level
  • VLN $1.88
  • NBTX $8.03
  • Resistance Level
  • VLN $2.08
  • NBTX $9.14
  • Average True Range (ATR)
  • VLN 0.09
  • NBTX 0.56
  • MACD
  • VLN 0.00
  • NBTX -0.02
  • Stochastic Oscillator
  • VLN 1.56
  • NBTX 68.67

About VLN Valens Semiconductor Ltd.

Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Cross Industry Business, which includes solutions for the non-automotive verticals, including audio-video, industrial, machine vision and medical markets, that deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: